FIL Ltd lessened its holdings in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 39.9% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 1,043,977 shares of the pharmacy operator’s stock after selling 694,100 shares during the quarter. FIL Ltd owned 0.11% of Walgreens Boots Alliance worth $66,052,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also modified their holdings of the business. Nelson Roberts Investment Advisors LLC acquired a new position in Walgreens Boots Alliance in the first quarter valued at approximately $25,000. Horan Capital Advisors LLC. purchased a new stake in shares of Walgreens Boots Alliance in the first quarter valued at approximately $25,000. Murphy Pohlad Asset Management LLC purchased a new stake in shares of Walgreens Boots Alliance in the fourth quarter valued at approximately $29,000. Trustcore Financial Services LLC purchased a new stake in shares of Walgreens Boots Alliance in the first quarter valued at approximately $31,000. Finally, PRW Wealth Management LLC purchased a new stake in shares of Walgreens Boots Alliance in the fourth quarter valued at approximately $34,000. 61.52% of the stock is owned by institutional investors and hedge funds.
Several brokerages recently commented on WBA. ValuEngine upgraded Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research report on Friday. JPMorgan Chase & Co. dropped their price target on Walgreens Boots Alliance from $74.00 to $73.00 and set an “overweight” rating for the company in a research report on Friday. BidaskClub cut Walgreens Boots Alliance from a “sell” rating to a “strong sell” rating in a research report on Monday, June 24th. Zacks Investment Research cut Walgreens Boots Alliance from a “hold” rating to a “sell” rating and set a $53.00 price target for the company. in a research report on Monday, June 10th. Finally, Bank of America dropped their price target on Walgreens Boots Alliance from $53.00 to $51.00 and set an “underperform” rating for the company in a research report on Monday, June 3rd. Six research analysts have rated the stock with a sell rating, ten have assigned a hold rating and four have issued a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $63.82.
Shares of WBA traded down $0.02 during mid-day trading on Monday, reaching $54.65. The company’s stock had a trading volume of 5,041,762 shares, compared to its average volume of 6,374,675. Walgreens Boots Alliance Inc has a 12-month low of $49.31 and a 12-month high of $86.31. The firm has a market capitalization of $49.37 billion, a PE ratio of 9.08, a PEG ratio of 1.12 and a beta of 0.82. The company has a current ratio of 0.76, a quick ratio of 0.37 and a debt-to-equity ratio of 0.49. The firm’s 50 day moving average price is $52.17.
Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Thursday, June 27th. The pharmacy operator reported $1.47 EPS for the quarter, beating analysts’ consensus estimates of $1.42 by $0.05. Walgreens Boots Alliance had a return on equity of 22.08% and a net margin of 3.53%. The business had revenue of $34.59 billion for the quarter, compared to the consensus estimate of $34.52 billion. During the same quarter in the prior year, the business posted $1.53 EPS. The business’s revenue for the quarter was up .7% on a year-over-year basis. Sell-side analysts forecast that Walgreens Boots Alliance Inc will post 5.98 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which was paid on Wednesday, June 12th. Investors of record on Monday, May 20th were paid a dividend of $0.44 per share. The ex-dividend date of this dividend was Friday, May 17th. This represents a $1.76 dividend on an annualized basis and a yield of 3.22%. Walgreens Boots Alliance’s dividend payout ratio is presently 29.24%.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.